<DOC>
	<DOC>NCT00081575</DOC>
	<brief_summary>To compare the efficacy and safety of IV tigecycline to IV levofloxacin in the treatment of subjects with CAP requiring hospitalization.</brief_summary>
	<brief_title>Study Comparing Tigecycline vs. Levofloxacin in Subjects Hospitalized With Community-Acquired Pneumonia</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Pneumonia</mesh_term>
	<mesh_term>Pneumonia, Bacterial</mesh_term>
	<mesh_term>Community-Acquired Infections</mesh_term>
	<mesh_term>Cross Infection</mesh_term>
	<mesh_term>Levofloxacin</mesh_term>
	<mesh_term>Ofloxacin</mesh_term>
	<mesh_term>Tigecycline</mesh_term>
	<mesh_term>Minocycline</mesh_term>
	<criteria>Male and female subjects ≥ 18 years of age and in Bulgaria only ≤ 70 years of age Subjects hospitalized with CAP with a severity that requires IV antibiotic treatment for at least 7 days The presence of fever (within 24 hours before randomization) Any concomitant condition that, in the opinion of the investigator, would preclude an evaluation of a response or make it unlikely that the contemplated course of therapy could be completed (eg, life expectancy &lt;30 days). Hospitalization within 14 days before the onset of symptoms. Residence in a longterm care facility or nursing home ≥14 days before the onset of symptoms.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>February 2013</verification_date>
	<keyword>Bacterial Pneumonia</keyword>
</DOC>